Cryo-EM reveals an unprecedented binding site for NaV1. 7 inhibitors enabling rational design of potent hybrid inhibitors

M Kschonsak, CC Jao, CP Arthur, AL Rohou… - Elife, 2023 - elifesciences.org
The voltage-gated sodium (NaV) channel NaV1. 7 has been identified as a potential novel
analgesic target due to its involvement in human pain syndromes. However, clinically …

Molecular basis of opioid action: From structures to new leads

A Manglik - Biological psychiatry, 2020 - Elsevier
Since the isolation of morphine from the opium poppy over 200 years ago, the molecular
basis of opioid action has remained the subject of intense inquiry. The identification of …

[HTML][HTML] The impact of the secondary binding pocket on the pharmacology of class A GPCRs

A Egyed, DJ Kiss, GM Keserű - Frontiers in Pharmacology, 2022 - frontiersin.org
G-protein coupled receptors (GPCRs) are considered important therapeutic targets due to
their pathophysiological significance and pharmacological relevance. Class A receptors …

[HTML][HTML] Recent advances in structure, function, and pharmacology of class A lipid GPCRs: opportunities and challenges for drug discovery

RNV Krishna Deepak, RK Verma, YD Hartono… - Pharmaceuticals, 2021 - mdpi.com
Great progress has been made over the past decade in understanding the structural,
functional, and pharmacological diversity of lipid GPCRs. From the first determination of the …

[PDF][PDF] Cryo-EM structure of the β3-adrenergic receptor reveals the molecular basis of subtype selectivity

C Nagiri, K Kobayashi, A Tomita, M Kato, K Kobayashi… - Molecular Cell, 2021 - cell.com
The β 3-adrenergic receptor (β 3 AR) is predominantly expressed in adipose tissue and
urinary bladder and has emerged as an attractive drug target for the treatment of type 2 …

Different conformational responses of the β2-adrenergic receptor-Gs complex upon binding of the partial agonist salbutamol or the full agonist isoprenaline

F Yang, S Ling, Y Zhou, Y Zhang, P Lv… - National Science …, 2021 - academic.oup.com
G protein-coupled receptors (GPCRs) are responsible for most cytoplasmic signaling in
response to extracellular ligands with different efficacy profiles. Various spectroscopic …

GPCR allosteric modulator discovery

Y Wu, J Tong, K Ding, Q Zhou, S Zhao - Protein allostery in drug discovery, 2019 - Springer
G protein-coupled receptors (GPCRs) influence virtually every aspect of human physiology;
about one-third of all marketed drugs target members of this family. GPCR allosteric ligands …

[HTML][HTML] Pharmacological targeting of G protein-coupled receptor heteromers

E Moreno, N Casajuana-Martin, M Coyle… - Pharmacological …, 2022 - Elsevier
A main rationale for the role of G protein-coupled receptor (GPCR) heteromers as targets for
drug development is the putative ability of selective ligands for specific GPCRs to change …

Strategies for the discovery of biased GPCR ligands

M Bermudez, TN Nguyen, C Omieczynski… - Drug Discovery …, 2019 - Elsevier
Highlights•Biased GPCR modulators provide various therapeutic benefits.•The number of
newly identified biased ligands is constantly increasing.•Understanding underlying receptor …

Discovery of dual-target ligands binding to beta2-adrenoceptor and cysteinyl-leukotriene receptor for the potential treatment of asthma from natural products derived …

Q Liang, H Zuo, T Yang, J Yin, X Huang, J Wang… - European Journal of …, 2022 - Elsevier
The design, synthesis, and discovery of dual-target compounds are considered as a
promising strategy to develop new drugs with improved safety and efficacy compared with …